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Efficient glucose metabolism is critical for maintaining cel-
lular viability. Under normal nutrient and oxygen condi-
tions, glucose is converted to pyruvate, entering the
mitochondria for oxidative phosphorylation and ATP pro-
duction. Under hypoxia or nutrient stress, metabolism is
switched to glycolysis, increasing lactate production and
reducing mitochondrial respiration, a switch known to play
an important role in cancer cells, as defined by Otto
Warburg decades ago. Little is known whether chromatin
plays a role in carbohydrate flux. The yeast Sir2 protein is
an NAD-dependent histone deacetylase that senses the
metabolic status of the cell and functions as a chromatin
silencer to promote lifespan and genomic stability.
Recently, we discovered that the mammalian SIRT6 is a
chromatin factor that influences glucose metabolism and
DNA repair. In mice, SIRT6-deficiency provokes a pro-
found and lethal hypoglycemia which culminates in accel-
erated death. At the cellular level, SIRT6 inactivation leads
to increased cellular glucose uptake, higher lactate produc-
tion and decreased mitochondrial activity. Our results indi-
cate that SIRT6 directly regulates expression of several key
glycolytic genes. In this context, SIRT6 co-represses Hif1a,
acting as a histone H3 lysine9 (H3K9) deacetylase to inhibit
expression of glycolytic genes (Zhong et al, 2010). Strik-
ingly, our new studies indicate that the “glycolytic switch”
observed in the absence of SIRT6 provides a unique
growth advantage in the context of tumorigenesis. Indeed,
we find that SIRT6 deficiency causes transformation even
in the absence of oncogenic signaling, and SIRT6 levels
determine progression and disease-free survival in various
human cancers. Our results suggest that SIRT6 might play
a critical role in modulating the Warburg effect.
Published: 1 June 2012
Reference
1. Zhong L, D’Urso A, Toiber D, Sebastian C, Henry RE, Vadysirisack DD,
Guimaraes A, Marinelli B, Wikstrom JD, Nir T, Clish CB, Vaitheesvaran ,
Iliopoulos OB, Kurland I, Dor Y, Weissleder R, Shirihai OS, Ellisen L,
Espinosa JM, Mostoslavsky R: The histone deacetylase SIRT6 regulates
glucose homeostasis via Hif1a. Cell 2010, 140:280-293.
doi:10.1186/1753-6561-6-S3-O17
Cite this article as: Sebastian et al.: The histone deacetylase SIRT6, a
critical modulator of metabolism and tumorigenesis. BMC Proceedings
2012 6(Suppl 3):O17.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit The Massachusetts General Hospital Cancer Center, Harvard Medical School,
Boston, MA USA
Sebastian et al. BMC Proceedings 2012, 6(Suppl 3):O17
http://www.biomedcentral.com/1753-6561/6/S3/O17
© 2012 Sebastian et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.